Showing results (231-240 of 426) with videos related to
Sort By:
Pageof 43
Science Signaling|June 23, 2021
TSHZ2 is an EGF-regulated tumor suppressor that binds to the cytokinesis regulator PRC1 and inhibits metastasisMary L Uribe, Maik Dahlhoff, Rajbir N Batra, et al.Molecular Oncology|September 11, 2014
Targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapyNada Albarakati, Tarek M A Abdel-Fatah, Rachel Doherty, et al.International Journal of Cancer|January 10, 2021
Germline APOBEC3B deletion increases somatic hypermutation in Asian breast cancer that is associated with Her2 subtype, PIK3CA mutations and immune activationJia-Wern Pan, Muhammad Mamduh Ahmad Zabidi, Boon-Keat Chong, et al.Science Translational Medicine|October 27, 2012
Quantitative image analysis of cellular heterogeneity in breast tumors complements genomic profilingYinyin Yuan, Henrik Failmezger, Oscar M Rueda, et al.Cell Reports Methods|May 27, 2026
Real-time cell viability monitoring for high-throughput drug screening using tumor xenograft-derived cellsElham Esmaeilishirazifard, Daniel Guerrero-Romero, Allan J W Lui, et al.Nature Communications|March 9, 2021
Time-resolved single-cell analysis of Brca1 associated mammary tumourigenesis reveals aberrant differentiation of luminal progenitorsKarsten Bach, Sara Pensa, Marija Zarocsinceva, et al.Cancer Research|March 20, 2019
PDLIM2 Is a Marker of Adhesion and β-Catenin Activity in Triple-Negative Breast CancerOrla T Cox, Shelley J Edmunds, Katja Simon-Keller, et al.Oncogene|October 27, 2021
Clonal populations of a human TNBC model display significant functional heterogeneity and divergent growth dynamics in distinct contextsHendrik J Kuiken, Sabin Dhakal, Laura M Selfors, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 7, 2014
Replication of genetic polymorphisms reported to be associated with taxane-related sensory neuropathy in patients with early breast cancer treated with PaclitaxelJean E Abraham, Qi Guo, Leila Dorling, et al.The Lancet. Oncology|January 19, 2010
Predictive markers of anthracycline benefit: a prospectively planned analysis of the UK National Epirubicin Adjuvant Trial (NEAT/BR9601)John M S Bartlett, Alison F Munro, Janet A Dunn, et al.Pageof 43